or Try an Advanced Search...

    Technical Analysis for ATHE - Alterity Therapeutics Limited

    Grade Last Price % Change Price Change
    F 1.05 -6.25% -0.07
    ATHE closed down 6.25 percent on Wednesday, November 20, 2024, on 1.36 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ATHE trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    BB Squeeze Ended Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Bollinger Band Squeeze Range Contraction -6.25%
    Lower Bollinger Band Walk Weakness -6.25%
    Older End-of-Day Signals for ATHE ...

       Recent Intraday Alerts

    Alert Time
    Gapped Down (Partial) about 22 hours ago
    2x Volume Pace about 22 hours ago
    1.5x Volume Pace about 22 hours ago
    3x Volume Pace about 22 hours ago
    Down 5% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ATHE Chart by TradingView
    Basic chart:

    Profile

    Alterity Therapeutics Ltd formerly known as Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Neuroscience Alzheimer's Disease Parkinson's Disease Gastrointestinal Neurology Toxicology Treatment Of Parkinson's Disease Huntington's Disease Movement Disorders Pathology Anatomical Pathology Brain Cancer Neuropathology Toxicology Testing Treatment Of Alzheimer's

    Is ATHE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
    Oct 31 Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
    Oct 14 Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
    Oct 11 Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
    Oct 2 Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
    Sep 30 Alterity Therapeutics appoints Abby Macnish Niven as CFO
    Sep 30 Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
    Sep 23 Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
    Jul 31 Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
    Jul 24 Alterity Therapeutics to Present at MST Financial Webinar
    See more ATHE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.41
    52 Week Low 1.01
    Average Volume 12,216
    200-Day Moving Average 1.67
    50-Day Moving Average 1.23
    20-Day Moving Average 1.15
    10-Day Moving Average 1.14
    Average True Range 0.07
    RSI (14) 34.64
    ADX 16.45
    +DI 19.09
    -DI 20.91
    Chandelier Exit (Long, 3 ATRs) 1.07
    Chandelier Exit (Short, 3 ATRs) 1.27
    Upper Bollinger Bands 1.23
    Lower Bollinger Band 1.08
    Percent B (%b) -0.21
    BandWidth 12.82
    MACD Line -0.04
    MACD Signal Line -0.03
    MACD Histogram -0.006
    Fundamentals Value
    Market Cap 7.67 Million
    Num Shares 7.3 Million
    EPS -1.86
    Price-to-Earnings (P/E) Ratio -0.56
    Price-to-Sales 3.73
    Price-to-Book 0.99
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.14
    Resistance 3 (R3) 1.15 1.13 1.13
    Resistance 2 (R2) 1.13 1.11 1.13 1.12
    Resistance 1 (R1) 1.09 1.09 1.08 1.08 1.11
    Pivot Point 1.07 1.07 1.07 1.07 1.07
    Support 1 (S1) 1.03 1.05 1.02 1.02 0.99
    Support 2 (S2) 1.01 1.03 1.01 0.98
    Support 3 (S3) 0.97 1.01 0.98
    Support 4 (S4) 0.96